Dana Beitner-Johnson

Title: Dana Beitner-Johnson: Innovator in Addictive Disorder Treatments

Introduction

Dana Beitner-Johnson is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of addiction treatment through his innovative research and patent.

Latest Patents

Dana Beitner-Johnson holds a patent for "Methods for treating addictive disorders." This invention is broadly directed towards the treatment of addictive diseases or disorders. It specifically focuses on inhibiting or reversing the biochemical and neurophysiological changes that correlate with behavioral changes associated with addiction. The method involves administering brain-derived factor (BDNF) or neurotrophin-4 (NT-4) to individuals suffering from addictive disorders. This administration is effective in reversing behavioral changes linked to these conditions. Notably, the invention demonstrates that BDNF or NT-4 can inhibit or reverse increased expression of tyrosine hydroxylase and glial fibrillary acidic protein in the ventral tegmental area of the brain, as well as cyclic-AMP-dependent protein kinase activity in the nucleus accumbens. Dana Beitner-Johnson has 1 patent to his name.

Career Highlights

Throughout his career, Dana has worked with prominent organizations such as Regeneron Pharmaceuticals, Inc. and Yale University. His work in these institutions has allowed him to further his research and contribute to advancements in the treatment of addiction.

Collaborations

Dana has collaborated with esteemed colleagues, including Eric J. Nestler and Melissa T. Berhow. These partnerships have enriched his research and expanded the impact of his work in the field of addiction treatment.

Conclusion

Dana Beitner-Johnson is a pioneering inventor whose work in treating addictive disorders has the potential to change lives. His innovative methods and collaborations highlight the importance of research in addressing complex health issues.